메뉴 건너뛰기




Volumn 34, Issue 6, 2006, Pages 1661-1667

Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trial

Author keywords

Anemia; Erythropoietin; Hemoglobin; Pharmacodynamics; Pharmacokinetics; Transfusion

Indexed keywords

ERYTHROPOIETIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

EID: 33744546570     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000217919.22155.85     Document Type: Article
Times cited : (34)

References (17)
  • 1
    • 0033847343 scopus 로고    scopus 로고
    • Anemia of the critically ill: "Acute" anemia of chronic disease
    • Corwin HL, Krantz SB: Anemia of the critically ill: "Acute" anemia of chronic disease. Crit Care Med 2000; 28:3098-3099
    • (2000) Crit Care Med , vol.28 , pp. 3098-3099
    • Corwin, H.L.1    Krantz, S.B.2
  • 2
    • 9144245515 scopus 로고    scopus 로고
    • The CRIT Study: Anemia and blood transfusion in the critically ill. Current clinical practice in the United States
    • Corwin HL, Gettinger A, Pearl RG, et al: The CRIT Study: Anemia and blood transfusion in the critically ill. Current clinical practice in the United States. Crit Care Med 2004; 32:39-52
    • (2004) Crit Care Med , vol.32 , pp. 39-52
    • Corwin, H.L.1    Gettinger, A.2    Pearl, R.G.3
  • 3
    • 0037174359 scopus 로고    scopus 로고
    • Anemia and blood transfusion in critically ill patients
    • Vincent JL, Baron JF, Reinhart K, et al: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507
    • (2002) JAMA , vol.288 , pp. 1499-1507
    • Vincent, J.L.1    Baron, J.F.2    Reinhart, K.3
  • 4
    • 0033397526 scopus 로고    scopus 로고
    • Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients
    • von Ahsen N, Muller C, Serke S, et al: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27:2630-2639
    • (1999) Crit Care Med , vol.27 , pp. 2630-2639
    • Von Ahsen, N.1    Muller, C.2    Serke, S.3
  • 5
    • 0031039124 scopus 로고    scopus 로고
    • Erythropoietin response is blunted in critically ill patients
    • Rogiers P, Zhang H, Leeman M, et al: Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23:159-162
    • (1997) Intensive Care Med , vol.23 , pp. 159-162
    • Rogiers, P.1    Zhang, H.2    Leeman, M.3
  • 6
    • 0035092672 scopus 로고    scopus 로고
    • Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness
    • Rodriguez RM, Corwin HL, Gettinger A, et al: Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001; 16:36-41
    • (2001) J Crit Care , vol.16 , pp. 36-41
    • Rodriguez, R.M.1    Corwin, H.L.2    Gettinger, A.3
  • 7
    • 0033838942 scopus 로고    scopus 로고
    • Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
    • van Iperen CE, Gaillard CA, Kraaijenhagen RJ, et al: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28:2773-2778
    • (2000) Crit Care Med , vol.28 , pp. 2773-2778
    • Van Iperen, C.E.1    Gaillard, C.A.2    Kraaijenhagen, R.J.3
  • 8
    • 0032760409 scopus 로고    scopus 로고
    • Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
    • Corwin HL, Gettinger A, Rodriguez RM, et al: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27:2346-2350
    • (1999) Crit Care Med , vol.27 , pp. 2346-2350
    • Corwin, H.L.1    Gettinger, A.2    Rodriguez, R.M.3
  • 9
    • 0037065340 scopus 로고    scopus 로고
    • Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial
    • Corwin HL, Gettinger A, Pearl RG, et al: Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002; 288:2827-2835
    • (2002) JAMA , vol.288 , pp. 2827-2835
    • Corwin, H.L.1    Gettinger, A.2    Pearl, R.G.3
  • 10
    • 0031044609 scopus 로고    scopus 로고
    • Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
    • Procrit Study Group
    • Glaspy J, Bukowski R, Steinberg D, et al: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997; 15:1218-1234
    • (1997) J Clin Oncol , vol.15 , pp. 1218-1234
    • Glaspy, J.1    Bukowski, R.2    Steinberg, D.3
  • 11
    • 0031785826 scopus 로고    scopus 로고
    • Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
    • Procrit Study Group
    • Demetri GD, Kris M, Wade J, et al: Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998; 16:3412-3425
    • (1998) J Clin Oncol , vol.16 , pp. 3412-3425
    • Demetri, G.D.1    Kris, M.2    Wade, J.3
  • 12
    • 0035367087 scopus 로고    scopus 로고
    • Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
    • Littlewood TJ, Bajetta E, Nortier JW, et al: Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001; 19:2865-2874
    • (2001) J Clin Oncol , vol.19 , pp. 2865-2874
    • Littlewood, T.J.1    Bajetta, E.2    Nortier, J.W.3
  • 13
    • 0031684212 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects
    • Cheung WK, Goon BL, Guilfoyle MC, et al: Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. Clin Pharmacol Ther 1998; 64:412-423
    • (1998) Clin Pharmacol Ther , vol.64 , pp. 412-423
    • Cheung, W.K.1    Goon, B.L.2    Guilfoyle, M.C.3
  • 14
    • 0035433756 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly
    • Cheung W, Minton N, Gunawardena K: Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly. Eur J Clin Pharmacol 2001; 57:411-418
    • (2001) Eur J Clin Pharmacol , vol.57 , pp. 411-418
    • Cheung, W.1    Minton, N.2    Gunawardena, K.3
  • 15
    • 0035366382 scopus 로고    scopus 로고
    • Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
    • Gabrilove JL, Cleeland CS, Livingston RB, et al: Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001; 19:2875-2882
    • (2001) J Clin Oncol , vol.19 , pp. 2875-2882
    • Gabrilove, J.L.1    Cleeland, C.S.2    Livingston, R.B.3
  • 16
    • 0031735051 scopus 로고    scopus 로고
    • Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study
    • Vincent JL, de Mendonça A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study. Crit Care Med 1998; 26:1793-1800
    • (1998) Crit Care Med , vol.26 , pp. 1793-1800
    • Vincent, J.L.1    De Mendonça, A.2    Cantraine, F.3
  • 17
    • 0025241454 scopus 로고
    • Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers
    • McMahon FG, Vargas R, Ryan M, et al: Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990; 76:1718-1722
    • (1990) Blood , vol.76 , pp. 1718-1722
    • McMahon, F.G.1    Vargas, R.2    Ryan, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.